Robert C. Stanton

23.5k total citations · 10 hit papers
73 papers, 6.8k citations indexed

About

Robert C. Stanton is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Nephrology. According to data from OpenAlex, Robert C. Stanton has authored 73 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Physiology and 16 papers in Nephrology. Recurrent topics in Robert C. Stanton's work include Diabetes Treatment and Management (16 papers), Nitric Oxide and Endothelin Effects (15 papers) and Neonatal Health and Biochemistry (13 papers). Robert C. Stanton is often cited by papers focused on Diabetes Treatment and Management (16 papers), Nitric Oxide and Endothelin Effects (15 papers) and Neonatal Health and Biochemistry (13 papers). Robert C. Stanton collaborates with scholars based in United States, China and Germany. Robert C. Stanton's co-authors include Jiongdong Pang, Joseph Loscalzo, Jane A. Leopold, Anne Ward Scribner, Vanita R. Aroda, Nuha A. ElSayed, Jane Jeffrie Seley, Priya Prahalad, Scott Kahan and Mary Lou Perry and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Robert C. Stanton

71 papers receiving 6.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

2022 559 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival

2012 539 citations Robert C. Stanton profile →
6. Glycemic Targets: Standards of Care in Diabetes—2023

2022 411 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
7. Diabetes Technology: Standards of Care in Diabetes—2023

2022 196 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023

2022 187 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023

2022 173 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023

2022 145 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
13. Older Adults: Standards of Care in Diabetes—2023

2022 126 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023

2022 113 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →
14. Children and Adolescents: Standards of Care in Diabetes—2023

2022 109 citations Nuha A. ElSayed, Grazia Aleppo et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert C. Stanton United States	42	2.7k	2.0k	1.3k	1.1k	801	73	6.8k
Luigi Laviola Italy	42	1.9k 0.7×	2.2k 1.1×	952 0.8×	1.4k 1.3×	450 0.6×	126	6.2k
Luís Henrique Santos Canani Brazil	39	1.8k 0.7×	1.3k 0.7×	786 0.6×	1.2k 1.1×	1.2k 1.5×	204	6.3k
Shigehiro Katayama Japan	45	2.5k 1.0×	2.7k 1.4×	1.2k 1.0×	1.1k 1.1×	748 0.9×	224	8.2k
Edgard Delvin Canada	50	1.1k 0.4×	1.4k 0.7×	1.2k 1.0×	939 0.9×	321 0.4×	157	6.4k
Berthold Hocher Germany	53	1.6k 0.6×	2.2k 1.1×	1.1k 0.9×	1.8k 1.7×	1.7k 2.1×	355	9.4k
Takeshi Nishikawa Japan	35	1.7k 0.6×	3.0k 1.5×	1.1k 0.8×	2.1k 2.0×	408 0.5×	109	8.1k
Cheng Hu China	42	1.4k 0.5×	2.5k 1.3×	1.1k 0.9×	1.2k 1.2×	280 0.3×	274	6.2k
Toyoshi Inoguchi Japan	46	1.9k 0.7×	3.0k 1.5×	1.3k 1.0×	2.3k 2.2×	637 0.8×	147	8.3k
Paolo Ferrari Italy	52	3.1k 1.2×	3.1k 1.6×	1.7k 1.3×	1.0k 1.0×	1.2k 1.5×	342	9.8k
Atsunori Kashiwagi Japan	44	1.7k 0.6×	2.0k 1.0×	929 0.7×	1.9k 1.8×	822 1.0×	158	7.0k

Countries citing papers authored by Robert C. Stanton

Since Specialization

Citations

This map shows the geographic impact of Robert C. Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Stanton more than expected).

Fields of papers citing papers by Robert C. Stanton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Stanton. The network helps show where Robert C. Stanton may publish in the future.

Co-authorship network of co-authors of Robert C. Stanton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Stanton. A scholar is included among the top collaborators of Robert C. Stanton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Stanton. Robert C. Stanton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S128–S139. 145 indexed citations breakdown →

Stanton, Robert C.. (2021). SGLT2 Inhibitors and Other Novel Therapeutics in the Management of Diabetic Kidney Disease. Seminars in Nephrology. 41(2). 85–95. 2 indexed citations

Stanton, Robert C., Alan Fleming, Enrico Pellegrini, et al.. (2019). Association of Systemic Comorbities with Predominantly Peripheral Diabetic Retinopathy Lesions (PPL) Identified on Ultrawide Field (UWF) Retinal Imaging. Investigative Ophthalmology & Visual Science. 60(9). 4772–4772. 2 indexed citations

Spencer, Netanya Y. & Robert C. Stanton. (2019). The Warburg Effect, Lactate, and Nearly a Century of Trying to Cure Cancer. Seminars in Nephrology. 39(4). 380–393. 86 indexed citations

Kleinridders, André, Heather A. Ferris, Michelle L. Reyzer, et al.. (2018). Regional differences in brain glucose metabolism determined by imaging mass spectrometry. Molecular Metabolism. 12. 113–121. 49 indexed citations

Yamanouchi, Masayuki, Jan Skupień, Monika A. Niewczas, et al.. (2017). Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. Kidney International. 92(1). 258–266. 38 indexed citations

Liu, Wenjuan, Xiaolan Lu, Qinghua Wang, et al.. (2016). Exogenous kallikrein protects against diabetic nephropathy. Kidney International. 90(5). 1023–1036. 31 indexed citations

Spencer, Netanya Y. & Robert C. Stanton. (2016). Glucose 6-phosphate dehydrogenase and the kidney. Current Opinion in Nephrology & Hypertension. 26(1). 43–49. 42 indexed citations

Spencer, Netanya Y., Ziying Yan, Le Cong, et al.. (2015). Definitive localization of intracellular proteins: Novel approach using CRISPR-Cas9 genome editing, with glucose 6-phosphate dehydrogenase as a model. Analytical Biochemistry. 494. 55–67. 6 indexed citations

10.

Skupień, Jan, James H. Warram, Adam M. Smiles, et al.. (2014). Improved Glycemic Control and Risk of ESRD in Patients with Type 1 Diabetes and Proteinuria. Journal of the American Society of Nephrology. 25(12). 2916–2925. 36 indexed citations

11.

Lei, Shulei, Laura Mireya Zavala-Flores, Aracely García‐García, et al.. (2014). Alterations in Energy/Redox Metabolism Induced by Mitochondrial and Environmental Toxins: A Specific Role for Glucose-6-Phosphate-Dehydrogenase and the Pentose Phosphate Pathway in Paraquat Toxicity. ACS Chemical Biology. 9(9). 2032–2048. 79 indexed citations

12.

Stanton, Robert C.. (2014). Clinical Challenges in Diagnosis and Management of Diabetic Kidney Disease. American Journal of Kidney Diseases. 63(2). S3–S21. 74 indexed citations

13.

Stanton, Robert C.. (2013). Combination Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Diabetic Kidney Disease. Current Diabetes Reports. 13(4). 567–573. 4 indexed citations

14.

Królewski, Andrzej S., James H. Warram, Carol Forsblom, et al.. (2012). Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes. Diabetes Care. 35(11). 2311–2316. 54 indexed citations

15.

Zhang, Zhaoyun, Zhihong Yang, Bo Zhu, et al.. (2012). Increasing Glucose 6-Phosphate Dehydrogenase Activity Restores Redox Balance in Vascular Endothelial Cells Exposed to High Glucose. PLoS ONE. 7(11). e49128–e49128. 45 indexed citations

16.

Skupień, Jan, James H. Warram, Adam M. Smiles, et al.. (2012). The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney International. 82(5). 589–597. 102 indexed citations

17.

Rosolowsky, Elizabeth, Jan Skupień, Adam M. Smiles, et al.. (2011). Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection. Journal of the American Society of Nephrology. 22(3). 545–553. 144 indexed citations

18.

Stanton, Robert C.. (2006). Diabetic Nephropathy and Oxidative Stress. US Endocrinology. 0(1). 2–2. 2 indexed citations

19.

Xu, Yizhen, Brent W. Osborne, & Robert C. Stanton. (2005). Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. American Journal of Physiology-Renal Physiology. 289(5). F1040–F1047. 172 indexed citations

20.

Zhang, Zhiquan, Kira Apse, Jiongdong Pang, & Robert C. Stanton. (2000). High Glucose Inhibits Glucose-6-phosphate Dehydrogenase via cAMP in Aortic Endothelial Cells. Journal of Biological Chemistry. 275(51). 40042–40047. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact